-
- Masahito Yamada.
- Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science.
- Rinsho Shinkeigaku. 2007 Nov 1; 47 (11): 805-8.
AbstractThe Creutzfeldt-Jakob Disease (CJD) Surveillance Committee, Japan, started in April 1999, and has identified 918 patients with prion diseases until March 2007, including 716 with sporadic CJD (78.0%), 128 with genetic prion diseases (14.0%), and 72 with environmentally acquired prion diseases (7.8%). Among atypical cases of sporadic CJD, most common was MM2 type including thalamic and cortical forms. The 128 genetic cases were classified to 42 with CJD with a PrP V180I mutation (32.9%), 26 with CJD with a E200K mutation (20.4%), 25 with GSS with a P102L mutation (19.6%), 17 with CJD with a M232R mutation (13.3%), 4 with a insertion mutation in the octapeptide repeat region (3.1%), 3 with GSS with a P105L mutation (2.5%), 2 with fatal familial insomnia with a D178N mutation (1.8%), and so on. The 72 patients with environmentally acquired prion diseases included 71 with dural graft-associated CJD (dCJD) and one with variant CJD (vCJD). Taken together with the results by the previous surveillance systems, a total number of dCJD in Japan was 129. The vCJD patient had a history of short stay in the UK and presented with periodic electroencephalogram in the late stage, requiring revision of the vCJD case definition (WHO 2001).
Notes
Knowledge, pearl, summary or comment to share?